The number one way to learn about the market
Investing doesn't have to be as hard as you think. With one email a day, you'll learn everything you need to know to make better choices with your money. See how over a million people are taking control of their wealth.
Proudly Featured In
Learn from the experts
Tap into our network of experienced analysts. From former hedge fund managers, multi-billion-dollar pension fund managers, advisors, traders, professors, accountants, financial lawyers, inventors and doctors, there's not a corner of the market we can't help you understand.
Our team will show you the best ways to protect and grow your money no matter what's happening in the market. We'll be with you every step of the way regardless of your starting point, your risk tolerance or your financial interests. You're guaranteed to find something you like.
Subscribers Worldwide
1M+
Editors & Analysts
33
No. of Products
31
No. of 10x Recommendations
24
Find what works for you
Whether you're just starting out or a seasoned professional, there's something for everyone. Each one of our 30+ research services are designed to protect and grow your wealth.
Join the 1M+ people growing their wealth with Stansberry Research
Given me an edge
Stansberry Research has given me an edge in facing the ever-changing times we are in - not everyone has found it as easy. Thank you, you do a great job.
Mervyn D.
Subscriber since 2013
Cashed out with about a 500% gain
We recently cashed out with about a 500% gain. You do good work. We're a retired couple, on a fixed income, so getting the growth in the IRA is very helpful.
David B.
Subscriber since 2000
Broadened my knowledge
Stansberry Research has broadened my knowledge in so many areas, including options and short sales that I never imagined I'd do. The recommended investments are so comprehensive, I love it!
Laura P.
Subscriber since 2015
I'm richer, smarter, and wiser
I have two degrees, an MBA, and PhD, and I have learned more about business and finance through Stansberry than all my degrees combined. I'm richer, smarter, and wiser today because of you.
Adriano R.
Subscriber since 2013
The means to achieve financial independence
I know the success I have had in the last three months, managing my own financial account and making gains during challenging times is due to the outstanding work and recommendations of Stansberry Research and the availability and support of the team. Partnering with Stansberry has given me the means to achieve financial independence.
Linda
Subscriber since 2020
Returns speak for themselves
I have been a member for years now and am a professional advisor, but I can't express my gratitude any more than looking at the returns I have generated this year by being an avid reader of all your newsletters. These returns speak for themselves. I can't thank you enough and feel honored to have found your services a few years back.
Pete C.
Subscriber since 2015
In the Stansberry Innovations Report, editor Eric Wade and our team of technology experts focus on the most pioneering and disruptive technologies around the world today.
The team looks for early opportunities in new technology trends that span the medical sciences, biotechnology, software, hardware, defense, and cryptocurrencies. These trends will likely play out over several years and decades.
Eric Wade
Editor
Largest Gain of Closed Position
446%
No. of 100%+ Winners
6
Model Portfolio Return vs S&P 500
+10.3%
Publication Overview
Publishing Schedule
Monthly (third Friday of every month) with email updates as needed
Required Capital
Approx. $1000 / Great for beginning investors, retirees, and those planning for retirement
Risk Tolerance
Conservative
Everything you need, all in one place
Nearly 1 in 2 Americans think they don't have enough money to enjoy retirement. We're changing the game. Sign up to get our best ideas every day the market's open.
Trending financial news
We watch the markets 24 hours a day, 365 days a year so you don't have to. Check out the latest issue of The Stansberry Digest, our flagship newsletter.
'DORK' Stocks: A Sign of the Times
More signs of speculative fervor… Stay away from the 'DORKs'... Margin debt hits an all-time high… Why lose some money when you can lose more?... Only two bigger peaks in this indicator… Beware the calm…
Stay away from the 'DORK' stocks...
We wrote to you last week about a return of "meme-stock mania" and a surge in a frenzy of speculation.
Shares of beaten-down companies like Kohl's (KSS), Krispy Kreme (DNUT), and Opendoor Technologies (OPEN) had been juiced higher by short-squeeze-seeking traders from Reddit's WallStreetBets online forum.
Remember, when a stock is heavily shorted, buying activity can prompt a virtuous price cycle. If the share price rises, short sellers begin cutting their losses by buying shares – pushing the price higher still. This puts a further "squeeze" on the shorts.
As we shared in the July 22 Digest...
On today's open, shares of Kohl's doubled. They gave back about 50% of that gain but were still sitting
Keep reading with a free account
Get access to the full article, plus access to our entire archive when you enter your email below.
The Housing Market Thaw Is Just Getting Started
Jul 29, 2025
The stock market has fully recovered from the initial tariff scare in April. But that threat has prolonged a deep freeze in another market...The U.S. housing market has been in gridlock since 2022, when the Federal Reserve began hiking interest rates. Higher mortgage rates crushed affordability – and activity in the housing market crashed.
Keep reading...
Tackle Head-Splitting Pain Without Pills
Jul 29, 2025
Imagine getting a brain freeze all of a sudden... only with no ice cream involved.That thoroughly unpleasant feeling jolted Emmy- and Tony-Award-winning actress Kristin Chenoweth's brain out of nowhere as she performed onstage.
Keep reading...
Episode 423: Venture Capital Is the Wild West of Investing
Jul 28, 2025
On this week's Stansberry Investor Hour, Dan and Corey welcome Joe Milam to the show. Joe is the founder and CEO of AngelSpan, which provides investor relations for early-stage startups. He's also the founder of The Legacy Funds and managing member of the Texas Legacy Fund.Joe kicks things off by recounting his background in finance and the "Forrest Gump-like experiences" that got him to where he is today. He critiques the venture-capital ("VC") world, as it requires no training or certification to enter. Joe explains that his mission is to bring professional standards and practices to early-stage VC. And he shares a few anecdotes of unprofessionalism in the VC world, including investing for access to a private jet, that you'll never hear reported by the media...
Listen to the episode
Three reasons why the 'miraculous' weight-loss drugs are back on my radar screen; Rebound Capital's GLP-1 basket; Big news from Novo Nordisk today sends shares plummeting; My view on Eli Lilly remains the same
Jul 29, 2025
Longtime readers will recall that in recent years, I've written numerous times about what I call the "miraculous" weight-loss drugs.And they're once again on my radar screen for three reasons, which I'll outline today...
Keep reading...